Stay updated with breaking news from Holly windler. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Patients with Guardian™ System alarms active experienced a substantial increase in new prescriptions or medication adjustments related to rate and rhythm...
EATONTOWN, N.J. and ORLANDO, Fla., June 13, 2023 (GLOBE NEWSWIRE) -- Avertix Medical, Inc. (“Avertix” or the “Company”), formerly known as Angel Medical Systems, Inc., a company focused on improving
Avertix Medical to Go Public via Merger with BIOS Acquisition Corporation (BIOS) streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
With 99% accuracy and within 30 minutes, institutions will simultaneously and accurately test residents, health workers and visitors for COVID-19 and Flu...
With 99% accuracy and within 30 minutes, institutions will simultaneously and accurately test residents, health workers and visitors for COVID-19 and Flu A/BLucira COVID-19 & Flu Test is the first... | December 6, 2022
CARLSBAD, Calif., May 13, 2022 (GLOBE NEWSWIRE) -- Acutus Medical (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac...
Acutus Medical Updates Time and Date of Fourth Quarter and Full Year 2021 Financial Results forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.
CARLSBAD, Calif., Jan. 19, 2022 -- Acutus Medical, Inc. , an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced a corporate... | January 19, 2022
Share: CARLSBAD, Calif., July 14, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (NASDAQ:AFIB) ("Acutus") today announced the pricing of its underwritten public offering of 5,500,000 shares of its common stock at a price to the public of $14.00 per share. All of the shares of common stock are being offered by Acutus. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Acutus, are expected to be $77.0 million. The offering is expected to close on July 19, 2021, subject to the satisfaction of customary closing conditions. In addition, Acutus has granted the underwriters a 30-day option to purchase up to an additional 825,000 shares of Acutus' common stock at the price to the public, less underwriting discounts and commissions.
Acutus Medical Reports First Quarter 2021 Financial Results CARLSBAD, Calif., May 12, 2021 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today reported results for the first quarter of 2021. Recent Highlights: Reported revenue of $3.6 million in the first quarter of 2021, compared to $1.6 million in the same quarter last year. Increased worldwide installed base of second generation AcQMap consoles to 57 as of March 31, 2021, up from 51 at the end of the prior quarter – bringing the total installed base of AcQMap consoles to 62 as of March 31, 2021. Commenced US IDE trial for the AcQBlate Force-Sensing Ablation Catheter and System.